Key result
ECG-based ML predicts sustained ventricular arrhythmias in non-ischemic cardiomyopathy with an AUC of 0.86.
Why the study?
Arrhythmic risk stratification in non-ischemic cardiomyopathy remains challenging, as current predictors like LVEF, late gadolinium enhancement, and genetic markers have limitations in identifying sustained ventricular arrhythmias.
Does an ECG-based machine learning model improve the prediction of sustained ventricular arrhythmias compared to established clinical risk factors in patients with non-ischemic cardiomyopathy?
Cohort (n=314)
No
Does an ECG-based machine learning model improve the prediction of sustained ventricular arrhythmias compared to established clinical risk factors in patients with non-ischemic cardiomyopathy?
An ECG-based machine learning model demonstrated superior predictive ability for sustained ventricular arrhythmias in non-ischemic cardiomyopathy compared to conventional clinical variables.
Answers are grounded in this paper and cite their sources.
May support ECG-ML for SVA risk stratification in non-ischemic cardiomyopathy; leaves open prospective validation before clinical use.
Background Arrhythmic risk stratification in non-ischemic cardiomyopathy (NICM) remains challenging. Current predictors, such as left ventricular ejection fraction (LVEF) <35%, late gadolinium enhancement (LGE) and genetic markers have limitations in accurately identifying patients at risk for sustained ventricular arrhythmias (SVA). Our aim was to develop an ECG-based machine learning (ECG-ML) model to predict SVA in patients with NICM and to compare its predictive ability with established risk factors. Methods In this retrospective, single-center study, we included patients with NICM and no history of SVA, who had undergone baseline digitalized 12-lead ECG, genetic testing, and cardiac magnetic resonance. The primary outcome was SVA, defined as sudden cardiac death, sustained ventricular tachycardia or appropriate ICD intervention. A neural network–based model was developed using ECGs from 80% patients of the cohort (training cohort). Two model architectures were evaluated: an ECG-only model (ECG-ML) and a combined ECG-and-clinical model integrating ECG features with the patient's age at diagnosis, LVEF, the presence and type of LGE, and the presence of a pathogenic variant in a NICM-related or high arrhythmic-risk gene. Model performance was assessed in a separate validation cohort comprising the remaining 20% of patients. Results were compared with a clinical reference model incorporating the aforementioned clinical risk factors using Least Absolute Shrinkage and Selection Operator (LASSO) multivariate logistic regression. Results A total of 314 patients were included (68.5% male). The median age at diagnosis was 50.4 years (IQR 40.1–58.7), and the median LVEF was 28% (IQR 19–40%). LGE was present in 63.7% of patients, with 36.2% meeting high-risk criteria. Genetic testing was positive in 23% of patients, and 3.18% harbored a causal variant in high-risk genes. During a median follow-up of 3.91 years (IQR 2.27–4.58), 7.96% of patients developed SVA. The best-performing model was the ECG-ML model, which predicted SVA (p < 0.001) with a sensitivity of 75%, specificity of 85%, and an AUC of 0.86 (95% CI 0.57–1.00) in the validation cohort. No clinical covariate improved the ECG-ML model's performance. The clinical reference model, including LGE presence, high-risk LGE patterns, and a positive genotype, showed limited discriminative ability for predicting incident SVA (AUC 0.53; 95% CI 0.24–0.82). Neither LVEF nor the presence of a high-risk genotype were independent predictors of SVA in our cohort. Conclusion The ECG-based machine learning (ECG-ML) model demonstrated the potential to predict incident SVA in patients with NICM, with performance potentially surpassing that of conventional clinical variables. However, these findings are derived from a limited dataset and warrant confirmation in larger cohorts for external validation.
No takes yet. Share an insight, caveat, or question.
Garcia-Montero et al. (2026) conducted a cohort in Non-ischemic cardiomyopathy (NICM) (n=314). ECG-based machine learning (ECG-ML) model vs. Clinical reference model was evaluated on Sustained ventricular arrhythmias (SVA), defined as sudden cardiac death, sustained ventricular tachycardia or appropriate ICD intervention (AUC 0.86, 95% CI 0.57-1.00, p=<0.001). An ECG-based machine learning model predicted sustained ventricular arrhythmias in patients with non-ischemic cardiomyopathy with an AUC of 0.86.
Synapse has enriched 10 related papers. Consider them for comparative context: